The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Nick West
Showing 1-11 of 11 articles
Outcomes of optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation: one-year results from the ILUMIEN III: OPTIMIZE PCI trial
Ali Z,
Karimi Galougahi K,
Maehara A,
Shlofmitz R,
Fabbiocchi F,
Guagliumi G,
Alfonso F,
Akasaka T,
Matsumura M,
Mintz G,
Ben-Yehuda O,
Zhang Z,
Rapoza R,
West N,
Stone G
January 20, 2021 | 10.4244/EIJ-D-20-00498
Optical coherence tomography-guided coronary stent implantation compared to angiography: a multicentre randomised trial in PCI – design and rationale of ILUMIEN IV: OPTIMAL PCI
Ali Z,
Landmesser U,
Karimi Galougahi K,
Maehara A,
Matsumura M,
Shlofmitz R,
Guagliumi G,
Price M,
Hill J,
Akasaka T,
Prati F,
Bezerra H,
Wijns W,
Mintz G,
Ben-Yehuda O,
McGreevy R,
Zhang Z,
Rapoza R,
West N,
Stone G
January 20, 2021 | 10.4244/EIJ-D-20-00501
Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma Y,
Chevalier B,
Ono M,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabaté M,
Windecker S,
Rapoza R,
West N,
Reith S,
de Sousa Almeida M,
Campo G,
Iniguez-Romo A,
Serruys P
December 4, 2020 | 10.4244/EIJ-D-20-00024
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial
Smits P,
Chang C,
Chevalier B,
West N,
Gori T,
Barbato E,
Tarantini G,
Kocka V,
Achenbach S,
Dudek D,
Escaned J,
Wlodarczak A,
Abdel-Wahab M,
Esposito G,
Tijssen J,
Morice M,
Onuma Y,
van Geuns R
October 23, 2020 | 10.4244/EIJ-D-19-01079
Clinical outcomes of bioresorbable vascular scaffolds implanted with routine versus selective optical coherence tomography guidance: results from a single-centre experience
Flore V,
Brown A,
Giblett J,
Liou K,
Cranley J,
Hoole S,
West N
April 16, 2019 | 10.4244/EIJ-D-18-00262
Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: the ABSORB UK Registry
Baumbach A,
Zaman A,
West N,
O'Kane P,
Egred M,
Johnson TW,
Wheatcroft S,
Bowles R,
de Belder A,
Bouras G,
Lansky AJ,
Hill J,
Mathur A,
De Belder M,
Banning AP
January 19, 2018 | 10.4244/EIJ-D-17-00886
Implantation of bioresorbable vascular scaffolds following acute coronary syndrome is associated with reduced early neointimal growth and strut coverage
Giblett J,
Brown A,
Keevil H,
Jaworski C,
Hoole S,
West N
August 20, 2016 | 10.4244/EIJV12I6A117
Cholesterol crystals identified using optical coherence tomography and virtual histology intravascular ultrasound
Brown A,
Obaid D,
West N,
Goddard M,
Bennett M
June 19, 2015 | 10.4244/EIJV11I2A38
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I,
Verheye S,
Weissman N,
Barragan P,
Scott D,
Valdés Chávarri M,
West N,
Kelbæk H,
Whitbourn R,
Walters D,
Kubica J,
Thuesen L,
Masotti M,
Banning AP,
Sjogren I,
Stables R,
Allocco D,
Dawkins K
July 26, 2013 | 10.4244/EIJV9I3A52
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study
Danzi G,
Chevalier B,
Urban P,
Fath-Ordoubadi F,
Carrié D,
Wiemer M,
Serra A,
Wijns W,
Kala P,
Stabile A,
Ruigomez J,
Sagic D,
Laanmets P,
Strupp G,
West N,
Paunovic D
May 15, 2012 | 10.4244/EIJV8I1A17
Myocardial Injury following Coronary Artery Surgery versus Angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging
van Gaal W,
Arnold J,
Testa L,
Karamitsos T,
Lim C,
Ponnuthurai F,
Petersen S,
Francis J,
Selvanayagam J,
Sayeed R,
West N,
Westaby S,
Neubauer S,
Banning AP
January 20, 2011
1
Latest news
NEW ISSUE
A TAVI in Bicuspid Anatomies; TMVI; Bailout-TEER or Medical Therapy; DRT following LAAO; Cost-Effectiveness of FFR-Guided MVD Revascularisation in STEMI and more
June 24, 2022
AHEAD OF PRINT
Bioprosthetic dysfunction of the LOTUS valve
FREE ARTICLE - Rutger-Jan Nuis et al
June 17, 2022
AHEAD OF PRINT
Coronary access after ViV-TAVI with ACURATE neo2
FREE ARTICLE - Arif A. Khokhar et al.
June 16, 2022
AHEAD OF PRINT
Prognostic value of structural and functional microvascular dysfunction
FREE ARTICLE - Coen K.M. Boerhout et al
June 13, 2022
AHEAD OF PRINT
TAVR with the ACURATE neo2
FREE ARTICLE - Andrea Scotti et al
June 8, 2022
AHEAD OF PRINT
Antithrombotic strategy selection using smartphone technology
FREE ARTICLE - Jaya Chandrasekhar et al
June 3, 2022
AHEAD OF PRINT
The fingerprints of plaque rupture healing as detected by serial OCT imaging
FREE ARTICLE - Rocco Vergallo et al
June 2, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke